| 1 |
sodium-glucose cotransporter 2
(2454 times)
|
Endocrinology
(472 times)
|
T2DM (444 times)
HF (161 times)
T2D (161 times)
|
2001 Identification of a novel form of renal glucosuria with overexcretion of arginine, carnosine, and taurine.
|
| 2 |
sodium-dependent glucose cotransporter 2
(93 times)
|
Chemistry
(29 times)
|
T2DM (8 times)
GLP-1 (7 times)
DPP-4 (6 times)
|
2008 Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.
|
| 3 |
sodium-glucose transporter type 2
(4 times)
|
Vascular Diseases
(1 time)
|
GLP-1 (1 time)
|
2020 Mechanisms of SGLT2 (Sodium-Glucose Transporter Type 2) Inhibition-Induced Relaxation in Arteries From Human Visceral Adipose Tissue.
|
| 4 |
sodium-glucose type 2
(3 times)
|
Medicine
(3 times)
|
GLP-1 (2 times)
CV (1 time)
T2D (1 time)
|
2017 [Cardiovascular and renal protection of patients with type 2 diabetes : focus after EMPA-REG OUTCOME and LEADER].
|
| 5 |
sodium glucose-dependent renal transporter 2
(2 times)
|
Pharmacology
(1 time)
|
HFD32 (1 time)
MCP (1 time)
NASH (1 time)
|
2015 Pharmacokinetics and Pharmacodynamics of the SGLT2 Inhibitor Remogliflozin Etabonate in Subjects with Mild and Moderate Renal Impairment.
|
| 6 |
should include asodium glucose co-transporter2
(1 time)
|
Internal Medicine
(1 time)
|
HFpEF (1 time)
|
2022 [Update on diastolic heart failure].
|
| 7 |
SLC5A2 gene, which codes for Na+-glucose co-transporters 2
(1 time)
|
Natural Science Disciplines
(1 time)
|
FRG (1 time)
|
2016 A recurrent deletion in the SLC5A2 gene including the intron 7 branch site responsible for familial renal glucosuria.
|
| 8 |
Sodium-dependent glucose cotransporter 2 inhibitors
(1 time)
|
|
CANA (1 time)
CV (1 time)
DAPA (1 time)
|
2022 Canagliflozin and Dapagliflozin Attenuate Glucolipotoxicity-Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Inhibition of Sodium-Glucose Cotransporter-1.
|
| 9 |
sodium/glucose cotransporter 1 (SGLT1)and 2
(1 time)
|
Obesity
(1 time)
|
SGLT1 (1 time)
|
2020 Licogliflozin, a Novel SGLT1 and 2 Inhibitor: Body Weight Effects in a Randomized Trial in Adults with Overweight or Obesity.
|
| 10 |
study indicates that Na+-glucose cotransporter-2
(1 time)
|
Nephrology
(1 time)
|
DAPA (1 time)
RAAS (1 time)
|
2022 SGLT2 inhibition effect on salt-induced hypertension, RAAS, and Na+ transport in Dahl SS rats.
|
A Search Service for Abbreviation / Long Form